US Bancorp’s Ambrx Biopharma Inc AMAM Stock Holding History

US Bancorp’s Portfolio AMAM Stock Details AMAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-906	Closed	-$12.9K	–	4147
2023 Q4	$12.9K	Sell	906 -112	-11%	-$1.27K	﹤0.01%	3230
2023 Q3	$11.7K	Hold	1,018	–	–	﹤0.01%	3112
2023 Q2	$16.8K	Buy	+1,018	New	+$12.8K	﹤0.01%	3061

US Bancorp's AMAM Position: Q1 2024 in Review

US Bancorp sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 906 shares — an estimated $12.9K sold.

US Bancorp first reported a position in AMAM in Q2 2023 and held it in 3 quarters. The position peaked at $16.8K in Q2 2023. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.

US Bancorp reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
US Bancorp sold 906 Ambrx Biopharma Inc shares in Q1 2024, an estimated $12.9K.
US Bancorp first reported a position in Ambrx Biopharma Inc in Q2 2023 and held it in 3 quarters.
US Bancorp's Ambrx Biopharma Inc position peaked at $16.8K in Q2 2023.
0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.

Based on US Bancorp's 13F filing for Q1 2024, filed 8 May 2024.